Characterization and preparation of core-shell type nanoparticle for encapsulation of anticancer drug

Colloids and Surfaces B: Biointerfaces

Volumn 81, Issue 2, 2010, Pages 530-536

  Jang, Mi Kyeong ^a   Jeong, Young Il ^a   Nah, Jae Woon ^a  

^a Sunchon National University   (South Korea)

Author keywords

Hydrophobic anticancer drug; LMWSC; Nanoparticle; Paclitaxel; Tumor inhibition

Indexed keywords

ANTI-CANCER DRUG DELIVERY; ANTI-TUMOR ACTIVITIES; ANTICANCER DRUG; CORE SHELL STRUCTURE; CORE-SHELL; DELIVERY VEHICLE; DIALYSIS METHOD; IN-VIVO; LMWSC; LOW MOLECULAR WEIGHT; METHOXYPOLYETHYLENE GLYCOL; MOUSE TUMORS; NMR ANALYSIS; PACLITAXEL; SURVIVAL RATE; TUMOR CELLS; TUMOR GROWTH; TUMOR INHIBITION; WATER-SOLUBLE CHITOSAN;

CYTOTOXICITY; DIALYSIS; DIALYSIS MEMBRANES; DRUG DELIVERY; HYDROPHOBICITY; MOTION PICTURE EXPERTS GROUP STANDARDS; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; SHELLS (STRUCTURES); TUMORS;

HYDROGELS;

CHITOSAN DERIVATIVE; LOW MOLECULAR WEIGHT WATER SOLUBLE CHITOSAN; METHOXYPOLYETHYLENE GLYCOL; NANOPARTICLE; PACLITAXEL; POLYMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIALYSIS MEMBRANE; DRUG CYTOTOXICITY; DRUG DOSE COMPARISON; DRUG MEGADOSE; FEMALE; HYDROPHOBICITY; LOW DRUG DOSE; MEMBRANE TRANSPORT; MOUSE; NANOENCAPSULATION; NANOPHARMACEUTICS; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SURVIVAL RATE; SUSTAINED DRUG RELEASE; TUMOR; TUMOR REGRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL PROLIFERATION; CHITOSAN; CHOLESTEROL; DISEASE MODELS, ANIMAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; MICE; MICE, INBRED BALB C; MOLECULAR CONFORMATION; MOLECULAR WEIGHT; NANOPARTICLES; NEOPLASM TRANSPLANTATION; PACLITAXEL; PARTICLE SIZE; POLYETHYLENE GLYCOLS; SOLUBILITY; SURFACE PROPERTIES;

EID: 77956648913     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2010.07.053     Document Type: Article

References (45)

1. Rowinsky E.K., Donehow R.C. N. Engl. J. Med. 1995, 332:1004-1014.
2. Thigpen J.T. Semin. Oncol. 2000, 27:11-16.
3. Ishitobi M., Shin E., Kikkawa N. Int. J. Clin. Oncol. 2001, 6:55-58.
4. Chang A.Y., Rubins J., Asbury R., Boros L., Hui L.F. Semin. Oncol. 2001, 28:10-13.
5. Dhillon T., Stebbing J., Bower M. Expert Rev. Anticancer Ther. 2005, 5:215-219.
6. Weiss R., Donehower R.C., Wiernik P.H. J. Clin. Oncol. 1990, 8:1263-1268.
7. Liggins R.T., Hunter W.L., Burt H.M. J. Pharm. Sci. 1997, 86:1458-1463.
8. Lundberg B. J. Pharm. Pharmacol. 1997, 49:16-21.
9. Tarr B.D., Sambandan T.G., Yalkowsky S.H. Pharm. Res. 1987, 4:162-165.
10. Alkan-Onyuksel H., Ramakrishnan S., Chai H.-B., Pezzuto J.M. Pharm. Res. 1994, 11:206-212.
11. Greenwald R., Gilbert C.W., Pendri A. J. Med. Chem. 1996, 39:424-431.
12. Zhang X., Jackson J.K., Burt H.M. Int. J. Pharm. 1996, 132:195-206.
13. Yokoyama M., Miyauchi M., Yamada N., Okano T., Sakurai Y., Kataoka K., Inoue S. Cancer Res. 1990, 50:1693-1700.
14. Kataoka K., Kwon G.S., Yokoyama M., Okano T., Sakurai Y. J. Control. Release 1993, 24:119-132.
15. Jeong Y.I., Seo S.J., Park I.K., Lee H.C., Kang I.C., Akaike T., Cho C.S. Int. J. Pharm. 2005, 296:151-161.
16. Harries M., Ellis P., Harper P. J. Clin. Oncol. 2005, 23:7768-7771.
17. Gaucher G., Poreba M., Ravenelle F., Leroux J.C. J. Pharm. Sci. 2007, 96:1763-1775.
18. Brigger I., Dubernet C., Couvreur P. Adv. Drug Deliv. Rev. 2002, 54:631-651.
19. Desai M.P., Labhasetwar V., Walter E., Levy R.J., Amidon G.L. Pharm. Res. 1997, 14:1568-1573.
20. Feng S.S., Huang G.F., Mu L. Ann. Acad. Med. Singapore 2000, 29:623-639.
21. Suh H., Jeong B., Rathi R., Kim S.W. J. Biomed. Mater. Res. 1998, 42:331-338.
22. Feng S., Huang G. J. Control. Release 2001, 71:53-69.
23. Jaeghere F.D., Allemann E., Leroux J.C., Stevels W., Feijen F., Doelker E., Gurny R. Pharm. Res. 1999, 16:859-866.
24. Kim S.Y., Lee Y.M. Biomaterials 2001, 22:1697-1704.
25. Lee S.C., Kim C., Kwon I.C., Chung H., Jeong S.Y. J. Control. Release 2003, 89:437-446.
26. Lee K.E., Kim B.K., Yuk S.H. Biomacromolecules 2002, 3:1115-1119.
27. Chandy T., Sharma C.P. Chitosan as a biomaterial. Biomater. Artif. Cells Artif. Organs 1990, 8:1-24.
28. Paul W., Sharma C.P. S. T. P. Pharma Sci. 2000, 10:5-22.
29. Nah J.W., Jang M.K. J. Polym. Sci. A: Polym. Chem. 2002, 40:3796-3803.
30. Jang M.K., Nah J.W. Bull. Korean Chem. Soc. 2003, 24:1303-1307.
31. Jeong Y.I., Kim D.G., Jang M.K., Nah J.W. Carbohydr. Res. 2008, 343:282-289.
32. Kim J.H., Kim Y.S., Kim S., Park J.H., Kim K., Choi K., Chung H., Jeong S.Y., Park R.W., Kim I.S., Kwon I.C. J. Control. Release 2006, 111:228-234.
33. Chae S.Y., Son S., Lee M., Jang M.K., Nah J.W. J. Control. Release 2005, 109:330-344.
34. Cuña M., Alonso-Sandel M., Remuñán-López C., Pivel J.P., Alonso-Lebrero J.L., Alonso M.J. J. Nanosci. Nanotechnol. 2006, 6:2887-2895.
35. Van Ta Q., Kim M.M., Kim S.K. Mar. Biotechnol. 2006, 8:593-599.
36. Chae S.Y., Jang M.K., Nah J.W. J. Control. Release 2005, 102:383-394.
37. Lee M., Nah J.W., Kwon Y., Koh J.J., Ko K.S., Kim S.W. Pharm. Res. 2001, 18:427-431.
38. Miwa A., Ishibe A., Nakano M., Yamahira T., Itai S., Jinno S., Kawahara H. Pharm. Res. 1998, 15:1844-1850.
39. Cavalli R., Caputo O., Carlotti E.M., Trotta M., Scarnecchia C., Gasco M.R. Int. J. Pharm. 1999, 148:47-54.
40. Chacon M., Molpeceres J., Berges L., Guzman M., Aberturas M.R. Eur. J. Pharm. Sci. 1999, 8:99-107.
41. De Chasteigner S., Cave G., Fessi H., Devissaguet J.P., Puisieux F. Drug Dev. Res. 1996, 38:116-124.
42. Yuan F., Leuning M., Huang S.K., Berk D.A., Papahadjopoulos D., Jain R.K. Cancer Res. 1994, 54:3352-3356.
43. Gref R., Minamitake Y., Peracchia M.T., Trubetskoy V., Torchilin V., Langer R. Science 1994, 263:1600-1603.
44. Cho Y.W., Lee J., Lee S.C., Huh K.M., Park K. J. Control. Release 2004, 97:249-257.
45. Kim S.C., Kim D.W., Shim Y.H., Bang J.S., Oh H.S., Kim S.W., Seo M.H. J. Control. Release 2001, 72:191-202.